FR2317302B1 - - Google Patents

Info

Publication number
FR2317302B1
FR2317302B1 FR7619245A FR7619245A FR2317302B1 FR 2317302 B1 FR2317302 B1 FR 2317302B1 FR 7619245 A FR7619245 A FR 7619245A FR 7619245 A FR7619245 A FR 7619245A FR 2317302 B1 FR2317302 B1 FR 2317302B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7619245A
Other languages
French (fr)
Other versions
FR2317302A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of FR2317302A1 publication Critical patent/FR2317302A1/fr
Application granted granted Critical
Publication of FR2317302B1 publication Critical patent/FR2317302B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FR7619245A 1975-06-24 1976-06-24 Procede de preparation d'antibiotiques du type b-lactame Granted FR2317302A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752528077 DE2528077A1 (de) 1975-06-24 1975-06-24 Beta-lactamantibiotika, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
FR2317302A1 FR2317302A1 (fr) 1977-02-04
FR2317302B1 true FR2317302B1 (cs) 1980-07-11

Family

ID=5949818

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7619245A Granted FR2317302A1 (fr) 1975-06-24 1976-06-24 Procede de preparation d'antibiotiques du type b-lactame

Country Status (17)

Country Link
JP (1) JPS523094A (cs)
AT (1) AT348118B (cs)
AU (1) AU498095B2 (cs)
BE (1) BE843343A (cs)
CH (1) CH628056A5 (cs)
DD (1) DD132344A5 (cs)
DE (1) DE2528077A1 (cs)
DK (1) DK281176A (cs)
ES (1) ES449142A1 (cs)
FI (1) FI761806A7 (cs)
FR (1) FR2317302A1 (cs)
GB (1) GB1539053A (cs)
GR (1) GR60559B (cs)
IL (1) IL49848A0 (cs)
LU (1) LU75216A1 (cs)
NL (1) NL7606788A (cs)
SE (1) SE7607217L (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5331690A (en) * 1976-09-01 1978-03-25 Shionogi & Co Ltd Oxadithiacephalosporins
JPS61246187A (ja) * 1985-09-05 1986-11-01 Shionogi & Co Ltd １―オキサデチアセファム化合物の製造方法
JPH02117677A (ja) * 1989-09-22 1990-05-02 Shionogi & Co Ltd １―オキサデチアセフアム化合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2233067A1 (en) * 1973-06-12 1975-01-10 Beecham Group Ltd N-(thio)acyl carbamoyl-glycylamino-cephalosporin ic acids - as antibiotics esp. active against pseudomonas and gram neg. organisms producing cephalosporinase
DE2407715C2 (de) * 1974-02-18 1982-12-02 Bayer Ag, 5090 Leverkusen Cephalosporine, Verfahren zu ihrer Herstellung sowie Arzneimittel

Also Published As

Publication number Publication date
GR60559B (en) 1978-06-22
CH628056A5 (en) 1982-02-15
DD132344A5 (de) 1978-09-20
IL49848A0 (en) 1976-08-31
LU75216A1 (cs) 1977-03-15
AU498095B2 (en) 1979-02-08
AU1522276A (en) 1978-01-05
NL7606788A (nl) 1976-12-28
FR2317302A1 (fr) 1977-02-04
DE2528077A1 (de) 1977-01-20
JPS523094A (en) 1977-01-11
SE7607217L (sv) 1976-12-25
ES449142A1 (es) 1977-07-16
FI761806A7 (cs) 1976-12-25
AT348118B (de) 1979-01-25
DK281176A (da) 1976-12-25
BE843343A (fr) 1976-12-24
ATA461376A (de) 1978-06-15
GB1539053A (en) 1979-01-24

Similar Documents

Publication Publication Date Title
FR2333913B1 (cs)
JPS5711018B2 (cs)
FR2307880B1 (cs)
JPS5434069Y2 (cs)
FR2317302B1 (cs)
JPS5724920B2 (cs)
JPS51103361A (cs)
JPS5237590U (cs)
JPS51105986A (cs)
JPS5283450U (cs)
JPS5650802Y2 (cs)
JPS5615291Y2 (cs)
JPS5518453Y2 (cs)
JPS51119045U (cs)
JPS51128812U (cs)
JPS5259222U (cs)
JPS5276862U (cs)
IN139922B (cs)
JPS5232899U (cs)
JPS5212713U (cs)
JPS51141799U (cs)
JPS51129251U (cs)
DD118266A1 (cs)
CH599936A5 (cs)
CH600757A5 (cs)

Legal Events

Date Code Title Description
ST Notification of lapse